Medtech
US
APAC
EUROPE
  • Home
  • Insights
  • Magazine
  • Conferences
  • Newsletter
  • Subscribe
  • News
  • Whitepaper
  • About Us
×
#

Medical Tech Outlook Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook

Subscribe

loading

THANK YOU FOR SUBSCRIBING

BioDirection: A Full Continuum of Care for TBI

Top 10 In-Vitro Diagnostic Technology Solution Companies - 2019

Today, In-vitro diagnostics (IVDs) presents a faster, reliable, and cost-effective means to detect and treat diseases, along with monitoring therapy responses in patients. Despite the emerging economic and industry challenges, IVDs has become an integral part of modern healthcare and drives most of the medical decisions in the world. Caregivers can derive benefits from IVDs in many ways, ranging from diagnosing health conditions and preventing diseases or sequelae to monitoring drug therapies and improving patient outcomes. IVDs holds great importance in the global healthcare industry as it helps protect the health and safety of patients by fostering the best medical services.

The rising occurrence of chronic diseases, growing geriatric population, and the popularity of personalized care are all major factors that boost the significance of IVDs. Alongside, advanced technology such as AI, cloud, and data analytics are driving the delivery of robust solutions in the IVDs space. The current shift from a centralized laboratory testing to decentralized, point-of-care testing has clearly minimized the errors in tests and has set the stage for swift and efficient diagnosis and treatment in complicated cases.

Business requirements and goals differ for each healthcare organization and choosing the right solution provider from the multitude of IVDs technology vendors in the market can be quite toilsome. To help health providers carry out this task with utmost ease, a distinguished panel comprising CEOs, CIOs, VCs, industry analysts, and MedTech Outlook’s editorial board has narrowed down a list of IVDs solution providers who are on the forefront of innovative technologies and strategies.

We present to you the “Top 10 In-Vitro Diagnostic Technology Solution Providers - 2019.”

Top 10 In Vitro Diagnostic Solution Companies - 2020
Top 10 In-Vitro Diagnostic Technology Solution Companies - 2018

Nominate a Company

Our subscribers nominate the companies with whom they have collaborated and gotten results. If you think there is a company that deserves to be on our upcoming prestigious annual list of Top 10 In-Vitro Diagnostic Technology Solution Companies , please write to us about them and the reasons you think they need to be on the list

* 

Thank You!

checkmark

Your nomination request for upcoming annual list of "Top 10 In-Vitro Diagnostic Technology Solution Companies " has been Successfully Sent . We will be in touch with you shortly.

Data not inserted

Top In-Vitro Diagnostic Technology Solution Companies

BioDirection

BioDirection

Biodirection specializes in the comprehensive detection of TBIs, irrespective of the severity of injuries. Cashing in on the developmental strides taken by Harvard University in the area of Biomarkers, Biodirection identifies anomalous indicators that signify the possibility of a TBI, when an individual is faced with head trauma or a jolt to his or her body. The company has mobilized the TBI detection marketplace with an ingenious product that both compact and comprehensive, in terms of both applicability and utilization. Through a handheld analyzer and a disposable cartridge, the company can detect the severity of an injury within a few minutes

biodirection.com

CNA Diagnostics

CNA Diagnostics

CNA Diagnostics is a molecular diagnostics company developing novel diagnostic tests for a spectrum of complex diseases. The renowned in-vitro diagnostic company is developing rapid, accurate, and cost-effective molecular diagnostic solutions for key diseases in people, pets and production animals. The company’s proprietary technology and expertise often enable disease detection before the occurrence of any clinical signs, which opens up a wider avenue of therapeutic treatment options. Having specialized in the development and licensing of diagnostic tests, CNA Diagnostics is now exploring the commercialization of a human sepsis diagnostic that can identify the condition before symptoms start appearing

cnadiagnostics.com

Co-Diagnostics

Co-Diagnostics

Co-Diagnostics leverages the CoPrimer technology in enabling an inner reaction in the PCR tubes, thereby succeeding in eliminating the chances of PD formation in a PCR reaction. Bioengineered by Dr. Brent Satterfield, the owner of Co-Diagnostics, CoPrimer is a single molecule comprising a probe and a primer attached by a Polyethylene Glycol (PEG) Linker. The elimination of PDs has made it possible for Co-Diagnostics to assess multiple processes at the same time, besides focusing on different targets concurrently in the same reaction. Deemed as a ‘technical advance’ as it is 2.5 Mn times more effective in reducing amplification errors, CoPrimers’ specificity facilitates the real multiplexing that enables a single test to identify numerous conditions, attributes, or genetic sequences simultaneously

codiagnostics.com

Diagast

Diagast

DIAGAST’s goal is to help healthcare professionals transmit life with the help of the best blood group determination technologies. Even though it is not always a matter of life and death, transfusion errors are never acceptable. DIAGAST has developed unique expertise and know-how in the transfusion sector. These values allow healthcare professionals to insure the total transfusional compatibility between receivers and donors. Thus DIAGAST has combined biology with information technology, to make its equipment evolving in parallel with the best of the new technology

diagast.com

Epigenomics

Epigenomics

Revolutionize the way of cancer diagnostics using our unique, proprietary DNA methylation biomarker technology. Epigenomics develops and commercializes patient-friendly, blood-based diagnostic tests across multiple cancer indications with high medical need. Using blood as a liquid biopsy can improve patient access to cancer screening and thereby contribute to eradicate today’s deadliest cancer types such as colorectal, liver, and lung cancer. By leveraging our product pipeline and strong intellectual property, we aim to become a global leader in blood-based cancer detection

epigenomics.com

Fuller Laboratories

Fuller Laboratories

Fuller Laboratories, an in vitro diagnostics technology solution provider, is a pioneer in generating antigens corresponding to specific vector-borne diseases. Fuller Laboratories generally develops indirect immunofluorescence assays (IFA) for new or emerging agents. This reflects the most basic immunology, namely testing a bacterium or parasite against the immune (positive) or non-immune (negative) serum and then detecting this reaction with anti-human antibody tagged with fluorescein (FITC) microscopically. The positive reaction shows the pathogen in a host cell in most of the assays, the cell in which the intracellular pathogen is propagated in the BSL-2 or BSL-3 laboratory

fullerlaboratories.com

Genomic Vision

Genomic Vision

Genomic Vision develops novel diagnostic and drug discovery solutions based on its world-leading Molecular Combing Technology for DNA analysis. The company’s focus is on early cancer detection and drug therapy monitoring. Their diagnostic tests and drug discovery tools operate where genome dynamics and human illness intersect. The company possesses a unique capability for discovering genomic biomarkers implicated in the predisposition and development of many forms of cancer and in following and analyzing DNA replication during cell division. This provides a unique approach for evaluating the efficacy of new drugs on the cell cycle

genomicvision.com

Molbio Diagnostics

Molbio Diagnostics

Changing Paradigms in MDx testing – Anywhere , Anytime

molbiodiagnostics.com

Nirmidas Biotech

Nirmidas Biotech

Nirmidas Biotech provides innovative solutions to life science and healthcare problems and aims to improve the quality of human life. Nirmidas develops and manufactures breakthrough technologies in biological testing, assays, and imaging, based on a novel red to near-infrared fluorescence enhancing detection platform. The company aims to develop personal and portable diagnostic systems for early disease diagnosis and prognosis monitoring, as well as for population-based screening applications. Nirmidas Biotech's products lie at the intersection of life science research, in vitro diagnosis, and digital healthcare

www.nirmidas.com

Toolbox Medical Innovations

Toolbox Medical Innovations

Toolbox Medical Innovations is an ISO 13485 certified life science and diagnostic product development firm and full Clinical Research Organization (CRO). We help our customers turn their technology into user friendly, cost effective and clinically validated commercial products.Through Toolboxes, the company provides a wide range of services including consumable product design,prototyping, usability testing, manufacturing scale up and clinical research. All Tools are specifically tuned to meet the demanding needs of the point of care diagnostic/life science industry.The depth and breadth of our expertise and resources in this industry are unrivaled

www.toolboxmed.com

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Copyright © 2021 Medical Tech Outlook. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy Policy.
follow on linkedin
This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

in-vitro-diagnostics.medicaltechoutlook.com/vendors/top-in-vitro-diagnostic-technology-solution-companies-rid-36.html